CorneaGen
  • SURGEON PORTAL
  • Contact Us
  • CORNEAL TISSUE
    • Tissue Overview
    • Tissue Services
      • DSAEK
      • DMEK
      • Pre-Loaded DMEK
      • Ampho B
      • PKP
      • ALK
      • BrightMEM
      • FLAK
      • Non-Sterile Sclera
    • Tissue Reimbursement
    • Adverse Reaction Reporting
    • Regulatory Information
    • Request Tissue
  • Sterile Tissue
    • CTAK
    • VisionGraft
      • Glaucoma
      • Cornea
    • Sclera
    • Reimbursement
      • CTAK Reimbursement
      • VisionGraft Reimbursement
    • Adverse Reaction Reporting
    • Regulatory Information
  • CTAK
    • CTAK Overview
    • CTAK International
    • CTAK Reimbursement
  • Products
    • Products Overview
    • EndoSerter-PL
    • EndoSerter
    • Cannula
    • DescePro System
    • Donor Punch
    • Recipient Trephine
  • Education
    • Online Training
    • Educational Videos
    • Wet Labs
    • Fellows Program
  • About Us
    • Our People
    • Our Partners
    • Our Locations
    • Reimbursement
    • Gift of Sight
    • Insights & Updates
    • Core Commitments
    • Innovation
    • Careers
Request Tissue & Products Contact Us
Supply, Shipping and Logistic Challenges

Supply, Shipping and Logistic Challenges

March 3, 2026

Due to the worsening situation in the Middle East, airspace closures, government regulations, and the issuance of safety warnings in and around the Strait of Hormuz and the related air and sea areas have caused significant impacts on the performance of transportation logistics. Flight cancellations and delays are expected to impact both passenger and cargo traffic.

We are committed to doing all within our power and influence to ensure successful tissue shipments and delivery for your scheduled surgeries, but we ask for your understanding during this difficult period.

Expect:

  • Closure and/or restriction of ports and airspace
  • Suspension or rerouting of vessel and aircraft operations
  • Governmental orders, security advisories, and regulatory restrictions
  • Congestion, delays, and operational disruptions across affected trade lanes
  • We are actively monitoring the situation and coordinating closely with carriers and regions to ensure continuity, transparency, and customer support
  • This situation is impacting the entire global air and ocean freight market and is not limited to the Middle East region.

These events are unforeseen, unavoidable, and unfortunately outside of our control of. As a result, our ability to meet reasonable on-time transportation and delivery services may be delayed.

Should you have any questions, please do not hesitate to contact us.  Tissue@CorneaGen.com

Recent Articles

  • CEO Update – January 2026

    CEO Update – January 2026

    A Message from Bernie Iliakis, President & CEO of CorneaGen  As we...

    READ MORE
  • CorneaGen Joins Forces with Lions Eye Bank of Texas  

    CorneaGen proudly announces its integration of Lions Eye Bank of...

    READ MORE
  • Growing for Greater Impact: CorneaGen Expands in Orlando to Better Serve Surgeons and Patients

    Growing for Greater Impact: CorneaGen Expands in Orlando to Better Serve Surgeons and Patients

    CorneaGen is excited to share that our expanded Orlando facility is now fully operational,...

    READ MORE
  • CEO Update – September 2025

    CEO Update – September 2025

    As we transition into fall after a fast-paced summer, CorneaGen’s...

    READ MORE
Navigation
  • Corneal Tissue
  • Sterile Tissue
  • CTAK
  • Products
  • Education
  • About Us
  • Request Tissue
Helpful Information
  • Reimbursement assistance
  • Adverse reaction reporting
  • Regulatory Information
  • KAMRA Support
  • Careers
Legal
  • Privacy Policy
  • Proprietary Terms and conditions
  • Regulatory Information
  • Vendor Information
  • Billing Terms and Conditions
  • Purchase Order Terms and Conditions
Connect
  • Contact Us
CorneaGen

©2026 CorneaGen

CorneaGen